111P Reporting of late serious adverse drug reactions (ADRs) in drug labels of targeted anticancer agents

Autor: Stefanovski, D., Ribnikar, D., Manevski, D., Seruga, B.
Zdroj: In ESMO Open February 2024 9 Supplement 1
Databáze: ScienceDirect